The seroepidemiology of tetanus in Catalonia, Spain

Medical Microbiology and Immunology

Volumn 196, Issue 2, 2007, Pages 115-119

  Dominguez A ^a,b,d   Plans, P ^a   Costa, J ^c   Espunes J ^a   Cardenosa N ^a   Salleras, L ^b   Plasencia A ^a  

^a Directorate of Public Health   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

^c HOSPITAL CLÍNIC   (Spain)

^d AGÈNCIA DE SALUT PÚBLICA DE BARCELONA   (Spain)

Author keywords

Seroepidemiological survey; Tetanus; Tetanus vaccination

Indexed keywords

TETANUS ANTIBODY;

ADOLESCENT; ADULT; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SEROEPIDEMIOLOGY; SEROPREVALENCE; SEX DIFFERENCE; SPAIN; TETANUS; TETANUS PROPHYLAXIS; VACCINATION;

ADOLESCENT; ADULT; AGE FACTORS; AGED; CHILD; CHILD, PRESCHOOL; CLOSTRIDIUM TETANI; FEMALE; HUMANS; MALE; MIDDLE AGED; PREVALENCE; SEROEPIDEMIOLOGIC STUDIES; SPAIN; TETANUS; TETANUS ANTITOXIN; VACCINATION;

EID: 33947495940     PISSN: 03008584     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00430-007-0035-4     Document Type: Article

References (39)

1. Amela C, Pachón I (2000) Estudio seroepidemiológico: situación de las enfermedades vacunables en España. Instituto de salud Carlos III, Madrid
2. Aue A, Hennig H, Krüger S, Closius B, Kirchner H, Seyfarth M (2003) Immunity against diphtheria and tetanus in German blood donors. Med Microbiol Immunol 192:93-97
3. Bardenheier B, Prevots DR, Khetsuriani N, Wharton M (1998) Tetanus surveillance - United States, 1995-1997. Centers for Disease Control and Prevention. MMWR Surveill Summ 47:1-13
4. Bayas JM, Vilella A, Bertran MJ, Vidal J, Batalla J, Asenjo MA, Salleras L (2001) Immunogenecity and reactogenecity of the adult tetanus-diphtheria vaccine. How many doses are necessary? Epidemiol Infect 127:451-460
5. Black TP (2005) Clostridium tetani (Tetanus). In: Mandel GL, Bennelt JE, Dolin R (eds) Principles and practice of infectious diseases, 6th edn. Elsevier/Churchill Livingstone, Philadelphia, pp 2817-2822
6. Bonetti TCS, Succi RCM, Wechx LY, Tavares-Lopez L, de Moraes-Pinto MI (2004) Tetanus and diphtheria antibodies and response to a booster dose in Brazilian HIV-1-infected women. Vaccine 22:3707-3712
7. Caglar K, Karakus R, Aybay C (2005) Determination of tetanus antibodies by a double-antigen enzyme-linked immunosorbent assay in individuals of various age groups. Eur J Clin Microbiol Infect Dis 24:523-528
8. Carson PJ, Nichol KL, O'Brien J, Hilo P, Janoff EN (2000) Immune function and vaccine responses in healthy advanced elderly patients. Arch Intern Med 160:2017-2024
9. Cavuslu S, Oncul O, Altunay H, Ozsoy MF, Kocak N (2003) Seroprevalence of tetanus antibody in Turkish population and effectiveness of single-dose tetanus toxoid. Eur J Clin Microbiol Infect Dis 22:431-433
10. Centers for Disease Control and Prevention (2006) Recommended childhood and adolescent immunization schedule - United States, 2006. MMWR 54:Q1-Q4
11. Centers for Disease Control, Prevention (2005) Recommended adult immunization schedule - United States, 2005 - September 2006. MMWR 54:Q1-Q4
12. Centro Nacional de Epidemiología (2005) Comentario epidemiológico de las enfermedades de declaración obligatoria y sistema de información microbiológica. Boletín Epidemiológico Semanal 13:109-116
13. Cohen AL, Veenstra D (2006) Economic analysis of prevaccination serotesting compared with presumptive immunization for polio, diphtheria, and tetanus in internationally adopted and immigrant infants. Pediatrics 117:1650-1655
14. De Melker HE, Van Den Hof S, Berbers GA, Conyn-van Spaendonck MA (2003) Evaluation of the national immunisation programme in the Netherlands: immunity to diphtheria, tetanus, poliomyelitis, measles, mumps, rubella and Haemophilus influenzae type b. Vaccine 21:716-720
15. Dening MS, Roungou JB, Kristiansen M, Heron I, Yango A, Guenengafo A, Ndamobissi R (2002) Tetanus toxoid coverage as an indicator of serological protection against neonatal tetanus. Bull World Health Organ 80:696-703
16. Departamento de Salud (2005) Resumen de las enfermedades de declaración obligatoria en Cataluña durante el año 2004. Butlletí Epidemiològic de Catalunya XXVI:145-157
17. Dundar V, Yumuk Z, Ozturk-Dundar D, Erdogan S, Gacar G (2005) Prevalence of tetanus immunity in the Kocaeli Region, Turkey. Jpn J Infect Dis 58:279-282
18. Gidding HF, Backhouse JL, Burgess MA, Gilbert GL (2005) Immunity to diphtheria and tetanus in Australia: a national serosurvey. Med J Aust 183:301-304
19. Hayney MS, Love GD, Carlberg BM, Muller D (2003) Tetanus seroprevalence among farmers: a preliminary study. J Rural Health 19:109-112
20. Heyman DL (ed) (2004) Control of communicable disease manual, 18th edn. American Public Health Association, Washington, pp 528-534
21. Hüllstrung HD, Mäusezahl D, Feuz M. Herzog C, Conzelmann M, Zimmerli W (2003) Tetanus immunisation in geriatric patients with accidental wounds: how much is needed? Swiss Med Wkly 133:227-232
22. Inandi T, Ertekin V, Ayyildiz A (2002) Sero-epidemiology of tetanus antibody among the children in eastern Turkey. Public Health 116:379-382
23. Institut d'Estadística de Catalunya (2002) Anuari d'estadística 2001, Barcelona: Institut d'Estadística de Catalunya
24. Janout V, Matouskova I, Cizek L (2003) The 2001 serologic survey in the Czech Republic tetanus. Cent Eur J Public Health 11(Suppl):S13-S16
25. Kiliç D, Kaygusuz S, Saygun M, Çakmak A, Uzer H, Doganci L (2003) Seroprevalence of tetanus immunity among noninsulin-dependent diabetes mellitus patients. J Diabetes Complicat 17:258-263
26. Kurtoglu D, Gozalan A, Coplu N, Miyamurc K, Morita M, Egen B, Akin L (2004) Community-based seroepidemiology of tetanus in three selected provinces in Turkey. Jpn J Infect Dis 57:10-16
27. Maple PAC, Jones CS, Wall EC, Vyse E, Edmunds WJ, Andrews NJ, Miller E (2001) Immunity to diphtheria and tetanus in England and Wales. Vaccine 19:167-173
28. McQuillan GM, Kruszon-Moran D, Deforest A, Chu SY, Wharton M (2002) Serologic immunity to diphtheria and tetanus in the United States. Ann Intern Med 136:660-666
29. Mendrinou E, Konzelis A, Georgakapoulos P, Dodou V, Regli A (2004) Immunity to tetanus of a rural population in a Greek country. New Microbiol 27:187-189
30. Office of population censures and surveys (1980) Classification of occupations. OPSC, London
31. Pachón I, Amela C, de Ory F (2002) Age-specific seroprevalence of poliomyelitis, diphtheria and tetanus antibodies in Spain. Epidemiol Infect 129:535-541
32. Redwan El-RM, Al-Awady MK (2002) Prevalence of tetanus immunity in the Egyptian population. Hum Antibodies 11:55-59
33. Salleras L, Vidal J, Bruguera M, Gené J, Navas E, Batalla J, Bayas JM, Esteban R (1994) Vacunaciones del adulto. Med Clin (Barc) 102(Supl 1):42-55
34. Sauerbrei A, Groh A, Bischoff A, Prager J, Wutzler P (2002) Antibodies against vaccine-preventable diseases in pregnant women and their offspring in the eastern part of Germany. Med Microbiol Immunol (Berl) 190:167-172
35. Tamer A, Karabay O, Ekerbicer H, Tahtaci M, Selam B, Celebi H (2005) Impaired immunity against tetanus in type 2 diabetes. Med Sci Monit 11:CR580-CR584
36. Velarde C, Cordero AI, Elesh A, Gómez JA (2004) El reto de la protección antitetánica en los ancianos. Aten Primaria 33:524-525
37. Vidal J, Domínguez A, Plans P, Salleras L (2000) Seroepidemiología del tétanos en la población adulta de Cataluña, 1989-1996. Vacunas 1:153-156
38. Walory J, Grzesiowski P, Hryniewicz W (2000) Immunity against diphtheria and tetanus in the adult Polish population. Pol Merkuriusz Lek 9:687-692
39. Wassilak SG, Roper MH, Murphy TV, Orenstein WA (2004) Tetanus Toxoid. In: Plotkin SA, Orenstein WA (eds) Vaccines, 4th edn. Saunders, Philadelphia, pp 745-781